Philipp Erben

14PUBLICATIONS
54CO-AUTHORS
NanoelectronicsComputational physiologyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Jul 15, 2025
Unicorns transforming the practice of urology: value creation and allocation in the digital age.

Philipp Erben, Severin Rodler, Amin T Turki

|Jun 20, 2025
Proliferation and regeneration of the healthy human urothelium: A multi-scale simulation approach with 16 hypotheses of cell differentiation.

Fabian Siegel, Angelo Torelli, Minca Mattis

|Mar 11, 2023
An m6A-Driven Prognostic Marker Panel for Renal Cell Carcinoma Based on the First Transcriptome-Wide m6A-seq.

Frank Waldbillig, Felix Bormann, Manuel Neuberger

|Dec 19, 2022
Membranous NECTIN-4 Expression Frequently Decreases during Metastatic Spread of Urothelial Carcinoma and Is Associated with Enfortumab Vedotin Resistance.

Niklas Klümper, Damian J Ralser, Jörg Ellinger

|Jul 02, 2021
High Androgen Receptor mRNA Expression Is Associated with Improved Outcome in Patients with High-Risk Non-Muscle-Invasive Bladder Cancer.

Danijel Sikic, Helge Taubert, Ralph M Wirtz

|Jun 02, 2021
Integration of Spatial PD-L1 Expression with the Tumor Immune Microenvironment Outperforms Standard PD-L1 Scoring in Outcome Prediction of Urothelial Cancer Patients.

Veronika Weyerer, Pamela L Strissel, Reiner Strick

Pageof 3

Frequent Collaborators

2 joint publications

Johannes Breyer

2 joint publications

Frank Waldbillig

2 joint publications

Helge Taubert

2 joint publications

Jörg Ellinger